MD

MEDNAX
NYSE

Real-time Quotes | Nasdaq Last Sale

27.67
+1.63
+6.26%
After Hours: 27.67 0 0.00% 17:22 03/08 EST
OPEN
26.16
PREV CLOSE
26.04
HIGH
28.07
LOW
26.04
VOLUME
1.34M
TURNOVER
--
52 WEEK HIGH
29.26
52 WEEK LOW
7.37
MARKET CAP
2.37B
P/E (TTM)
-241.2380
1D
5D
1M
3M
1Y
5Y
Teleradiology Market Size, Competitive Landscape, CAGR of 18.2%, Research Methodology, Business Opportunities, Statistics and Industry Analysis Report by 2027
Mar 03, 2021 (Market Insight Reports) -- High target disease prevalence, product launches, increasing strategic developments such as partnerships and...
Market Insight Reports · 5d ago
Global teleradiology market to exhibit 14% CAGR during 2020-2027
Feb 25, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report LLC: As per the research report titled 'Global Teleradiology Market Size...
Market Insight Reports · 02/25 19:56
Mednax to Present at Upcoming Investor Conferences
Mednax, Inc. (NYSE: MD) today announced that it is scheduled to make presentations at two upcoming investor conferences.
BusinessWire · 02/22 11:45
MEDNAX's (MD) Q4 Earnings Fall Shy of Estimates, Tumble Y/Y
Zacks.com · 02/19 16:53
DJ Mednax Is Maintained at Outperform by Credit Suisse
Dow Jones · 02/19 14:35
DJ Mednax Price Target Cut to $25.00/Share From $26.00 by Credit Suisse
Dow Jones · 02/19 14:35
Credit Suisse Maintains Outperform on Mednax, Lowers Price Target to $25
Credit Suisse analyst A.J. Rice maintains Mednax (NYSE:MD) with a Outperform and lowers the price target from $26 to $25.
Benzinga · 02/19 14:26
--Analyst Actions: Deutsche Bank Adjusts Mednax PT to $17.50 From $14, Maintains Sell Rating
MT Newswires · 02/19 13:11
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MD. Analyze the recent business situations of MEDNAX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MD stock price target is 20.35 with a high estimate of 25.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 422
Institutional Holdings: 102.94M
% Owned: 120.22%
Shares Outstanding: 85.63M
TypeInstitutionsShares
Increased
54
20.67M
New
68
-2.24M
Decreased
77
9.88M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.78%
Healthcare Providers & Services
+1.00%
Key Executives
Chairman/Independent Director
Guy Sansone
Chief Executive Officer
Mark Ordan
Chief Financial Officer/Executive Vice President
C. Marc Richards
Executive Vice President/General Counsel/Secretary
Dominic Andreano
Executive Vice President
Nikos Nikolopoulos
Senior Vice President/Chief Accounting Officer
John Pepia
Vice President
Kevin Smith
Lead Director/Independent Director
Manuel Kadre
Director
Roger Medel
Independent Director
Karey Barker
Independent Director
Waldemar Carlo
Independent Director
Paul Gabos
Independent Director
Thomas McEachin
Independent Director
Michael Rucker
Independent Director
John Starcher
Independent Director
Shirley Weis
No Data
About MD
MEDNAX, Inc is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company's national network consist of physicians, including over physicians providing neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It also has affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. Its network also included other pediatric subspecialists, physicians providing pediatric intensive care, pediatric cardiology care, hospital-based pediatric care, pediatric surgical care, pediatric ear, nose and throat and pediatric ophthalmology services.

Webull offers kinds of MEDNAX Inc stock information, including NYSE:MD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MD stock methods without spending real money on the virtual paper trading platform.